← ANALYSTS · TIPRANKS
Mani Foroohar · Leerink Partners
Hits
43%
210 of 484 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−2.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
15
Buy / hold / sell: 9 / 5 / 1
Upside of the analyst’s targets
+106.7%
Average over 12 current targets, to the last price
The market’s answer to the ratings
+4.0%
Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 7on TipRanks 09:10 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Hold | $7.00 → $4.00−42.9% | +83.5% | +2.5%next day +4.2% · 5 days −11.8% | ↗ |
| Sep 16on TipRanks 08:50 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Hold | — | — | +2.5%next day −0.6% · 5 days −15.3% | ↗ |
| Sep 9on TipRanks 08:35 | ENGNenGene Holdings · $115M | Reiterated | Hold | $2.00 | +19.8% | −3.2%next day −3.7% · 5 days +4.3% | ↗ |
| Jun 4on TipRanks 06:40 | ABSIIWMAbSci · $1.5B | Initiated | Buy | $12.00 | +45.5% | +23.2%next day −10.2% · 5 days −8.8% | ↗ |
| May 15on TipRanks 11:20 | RGNXIWMRegenXBio · $473M | Reiterated | Buy | $18.00 → $17.00−5.6% | +145.5% | −7.2%next day −1.2% · 5 days +10.1% | ↗ |
| Apr 27on TipRanks 13:25 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Buy | $35.00 | +206.5% | −4.5%next day +1.7% · 5 days +6.0% | ↗ |
| Apr 2on TipRanks 06:15 | CAMPIWMCAMP4 Therapeutics Corporation · $216M | Reiterated | Buy | $8.00 → $9.00+12.5% | +183.9% | +0.1%next day 0.0% · 5 days −3.2% | ↗ |
| Mar 26on TipRanks 11:35 | ARWRArrowhead Pharmaceuticals · $8.2B | Reiterated | Hold | — | — | +1.8%next day −3.2% · 5 days −1.2% | ↗ |
| Feb 11on TipRanks Feb 12 10:45 | MRNAQQQSPYModerna · $94.4B | Reiterated | Sell | $17.00 → $12.00−29.4% | −94.5% | −3.5%next day +0.6% · 5 days +23.8% | ↗ |
| Dec 15on TipRanks Dec 19 08:55 | TNYATenaya Therapeutics · $126M | Reiterated | Buy | $3.00 → $2.00−33.3% | +426.3% | −6.1%next day −3.7% · 5 days −5.9% | ↗ |
| Dec 15on TipRanks 09:30 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Hold | $370 → $351−5.1% | +51.4% | −1.4%next day +0.2% · 5 days +3.2% | ↗ |
| Dec 15on TipRanks 09:30 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $75.00 → $86.00+14.7% | +29.5% | −0.7%next day +1.9% · 5 days +2.6% | ↗ |
| Dec 15on TipRanks 09:30 | IONSIonis Pharmaceuticals · $7.0B | Reiterated | Buy | $85.00 → $100+17.6% | +132.9% | −1.2%next day −1.5% · 5 days +1.1% | ↗ |
| Oct 15on TipRanks Oct 28 04:35 | RXRXIWMRecursion Pharmaceuticals · $2.2B | Reiterated | Hold | — | — | +14.8%next day −5.7% · 5 days −15.7% | |
| Oct 15on TipRanks Oct 28 04:30 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Buy | $56.00 → $74.00+32.1% | +50.3% | +3.1%next day −4.0% · 5 days −7.8% | |
| Oct 15on TipRanks Oct 28 04:25 | FDMTIWM4D Molecular Therapeutics · $711M | Reiterated | Buy | — | — | −0.5%next day +2.0% · 5 days +5.2% | |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗